BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference Pharmaceutical Investing
Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival in Patients With Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer Life Science Investing
Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults Life Science Investing
Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices Pharmaceutical Investing
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Supplemental Biologics License Application and European Medicines Agency Validates Application for Opdivo .... Pharmaceutical Investing
Bristol Myers Squibb to Participate in Cowen's 43rd Annual Health Care Conference Pharmaceutical Investing
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates Pharmaceutical Investing
Bristol Myers Squibb to Present Data Supporting its Cardiovascular Portfolio at the American College of Cardiology Annual Scientific Session Together With World Congress of Cardiology Pharmaceutical Investing
AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation Pharmaceutical Investing
